Immunotherapy: Programming Your Immune System to Target Cancer Cells

MUSC Health medical oncologist John M. Wrangle, M.D., and cancer immunologist Mark P. Rubinstein, Ph.D., discuss the promise of immunotherapy and their close collaboration that has led to a clinical trial of a novel combination immunotherapy for non-small cell lung cancer.

More at Progressnotes, MUSC’s Medical Magazine


Related Presenters

John M. Wrangle, MD.

John M. Wrangle, MD

Dr. John M. Wrangle is a board-certified medical oncologist. His clinical specialties include non-small cell lung cancer and small cell lung cancer. His medical degree was awarded by Tulane University School of Medicine. He completed a ...

View full profile

Mark P. Rubinstein, PhD.

Mark P. Rubinstein, PhD

Assistant Professor of Surgery Ph.D. awarded from the Medical University of South Carolina - 2002Postdoctoral Fellowships - Scripps Research Institute and University of California, San Diego - 2003-2008

View full profile

Related Videos